Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II)
- PMID: 18227223
- DOI: 10.1177/1087057107310806
Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II)
Abstract
Kinases are important drug discovery targets for a wide variety of therapeutic indications; consequently, the measurement of kinase activity remains a common high-throughput screening (HTS) application. Recently, enzyme-coupled luciferase-kinase (LK) format assays have been introduced. This format measures luminescence resulting from metabolism of adenosine triphosphate (ATP) via a luciferin/luciferase-coupled reaction. In the research presented here, 1536-well format time-resolved fluorescence resonance energy transfer (TR-FRET) and LK assays were created to identify novel Rho-associated kinase II (ROCK-II) inhibitors. HTS campaigns for both assays were conducted in this miniaturized format. It was found that both assays were able to consistently reproduce the expected pharmacology of inhibitors known to be specific to ROCK-II (fasudil IC50: 283 +/- 27 nM and 336 +/- 54 nM for TR-FRET and LK assays, respectively; Y-27632 IC50: 133 +/- 7.8 nM and 150 +/- 22 nM for TR-FRET and LK assays, respectively). In addition, both assays proved robust for HTS efforts, demonstrating excellent plate Z' values during the HTS campaign (0.84 +/- 0.03; 0.72 +/- 0.05 for LK and TR-FRET campaigns, respectively). Both formats identified scaffolds of known and novel ROCK-II inhibitors with similar sensitivity. A comparison of the performance of these 2 assay formats in an HTS campaign was enabled by the existence of a subset of 25,000 compounds found in both our institutional and the Molecular Library Screening Center Network screening files. Analysis of the HTS campaign results based on this subset of common compounds showed that both formats had comparable total hit rates, hit distributions, amount of hit clusters, and format-specific artifact. It can be concluded that both assay formats are suitable for the discovery of ROCK-II inhibitors, and the choice of assay format depends on reagents and/or screening technology available.
Similar articles
-
Discovery of novel scaffolds for Rho kinase 2 inhibitor through TRFRET-based high throughput screening assay.Comb Chem High Throughput Screen. 2013 Jan;16(1):37-46. doi: 10.2174/1386207311316010006. Comb Chem High Throughput Screen. 2013. PMID: 22934984
-
Fluorescence polarization and time-resolved fluorescence resonance energy transfer techniques for PI3K assays.Methods Mol Biol. 2009;572:161-76. doi: 10.1007/978-1-60761-244-5_10. Methods Mol Biol. 2009. PMID: 20694691
-
Development of a High-Throughput Assay for Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1 Based on Time-Resolved Fluorescence Energy Transfer.Biol Pharm Bull. 2017;40(9):1454-1462. doi: 10.1248/bpb.b17-00283. Biol Pharm Bull. 2017. PMID: 28867728
-
New Horizons on Molecular Pharmacology Applied to Drug Discovery: When Resonance Overcomes Radioligand Binding.Curr Radiopharm. 2017;10(1):16-20. doi: 10.2174/1874471010666170208152420. Curr Radiopharm. 2017. PMID: 28183248 Review.
-
Bioluminescent assays for high-throughput screening.Assay Drug Dev Technol. 2007 Feb;5(1):127-36. doi: 10.1089/adt.2006.053. Assay Drug Dev Technol. 2007. PMID: 17355205 Review.
Cited by
-
Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries.Bioorg Med Chem. 2009 Jul 15;17(14):5027-37. doi: 10.1016/j.bmc.2009.05.070. Epub 2009 Jun 22. Bioorg Med Chem. 2009. PMID: 19553129 Free PMC article.
-
Discovery of Potent and Selective Urea-Based ROCK Inhibitors and Their Effects on Intraocular Pressure in Rats.ACS Med Chem Lett. 2010 Apr 5;1(4):175-9. doi: 10.1021/ml1000382. eCollection 2010 Jul 8. ACS Med Chem Lett. 2010. PMID: 24900192 Free PMC article.
-
Discovery of novel inhibitors for the treatment of glaucoma.Expert Opin Drug Discov. 2015 Mar;10(3):293-313. doi: 10.1517/17460441.2015.1000857. Epub 2015 Jan 9. Expert Opin Drug Discov. 2015. PMID: 25575654 Free PMC article. Review.
-
Novel patient cell-based HTS assay for identification of small molecules for a lysosomal storage disease.PLoS One. 2011;6(12):e29504. doi: 10.1371/journal.pone.0029504. Epub 2011 Dec 21. PLoS One. 2011. PMID: 22216298 Free PMC article.
-
Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors.J Med Chem. 2008 Nov 13;51(21):6642-5. doi: 10.1021/jm800986w. Epub 2008 Oct 4. J Med Chem. 2008. PMID: 18834107 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources